///STI Technologies acquired by Quintiles IMS

STI Technologies acquired by Quintiles IMS

By | 2018-05-08T14:04:46+00:00 March 23rd, 2017|M&A News|

February 21st, 2017.  Halifax-based STI Technologies was acquired by QuintilesIMS (NYSE: Q -), the world’s largest provider of biopharmaceutical development and commercial outsourcing services for an amount reported by Allnovascotia.com to be about $200 million. Founded in 2001, STI received a $17 million investment from Imperial Capital Group to accelerate the Company’s Canadian market-leading intelligent reimbursement card technology.

Source: BetaKit

Transaction Details:

Date of Announcement2/10/2017
HeadlineQuintiles IMS acquires STI Technologies
SectorPharmaceuticals, Health Care, Biotechnology
Company AcquiredSTI Technologies
Company LocationHalifax, Nova Scotia
Private/PublicPrivate
Transaction Amount (reported)N/A
Founded2001
Employees51-200
Amount InvestedUS$17M1 Round1 Investor
Key InvestorsImperial Capital Group
AcquirerQuintiles IMS
Acquirer LocationDurham, North Carolina
Private/PublicPublic
Founded1982
Employees50,000+
Capital Raised to dateN/A
CommentThe combination of QuintilesIMS and STI Technologies' capabilities will enable our customers to deliver a better patient experience.
Press ReleaseBetaKit
Sourcecrunchbase
For more information:Click Here